tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
KROS
Keros Therapeutics
Stock Analysis
Analyst Forecasts
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Keros Therapeutics (KROS) Stock News & Sentiment

184 Followers
Keros Therapeutics Updates Corporate Presentation Online
PremiumCompany Announcements
Keros Therapeutics Updates Corporate Presentation Online
2M ago
8K
KROS
Keros Therapeutics CMO Simon Cooper Resigns
PremiumCompany Announcements
Keros Therapeutics CMO Simon Cooper Resigns
2M ago
8K
KROS
Keros Therapeutics CEO to Speak at Global Biopharma Conference
PremiumCompany Announcements
Keros Therapeutics CEO to Speak at Global Biopharma Conference
2M ago
8K
KROS
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
PremiumPress Releases
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
2M ago
KROS
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
2M ago
KROS
Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock
PremiumPress Releases
Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock
4M ago
KROS
Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
PremiumPress Releases
Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4M ago
KROS
More KROS News >

KROS News on the Web

Are Investors Undervaluing Keros Therapeutics, Inc. By 37%?
Yahoo Finance
Bullish
Buy Rating Affirmed for Keros Therapeutics Amid FDA Approval Landscape and Market Opportunity for KER-012
TipRanks News
Bullish
Should Biotechnology Stock Keros Therapeutics Inc (KROS) Be in Your Portfolio Wednesday?
Investors Observer
Neutral
Strong Buy Rating for Keros Therapeutics Amid Favorable LR-MDS Treatment Landscape and Regulatory Environment
TipRanks News
Bullish
Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes
Yahoo Finance
Neutral
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
Yahoo Finance
Neutral
Buy Rating Affirmed for Keros Therapeutics Amid Positive Clinical Progress and Strategic Catalysts
TipRanks News
Neutral
Optimistic Outlook for Keros Therapeutics’ Advancing Clinical Pipeline Justifies Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
KROS
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KROS’s Media Buzz Sentiment?
1 articles about KROS were published this week. In an average week, 1 articles are published.
    What is KROS’s weekly average amount of articles?
    In an average week, 1 articles about KROS are published.
      What is KROS’s News Sentiment?
      100% of articles about KROS were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        ELVElevance Health
        CGEMCullinan Management
        MRNSMarinus
        EWEdwards Lifesciences
        INSPInspire Medical Systems
        Showing the stocks with the most bullish news sentiment over the past week

        Get More with TipRanks Premium

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing